EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry

Ioana Agache iD, Maria Torres iD, Ibon Eguiluz-Gracia iD, Elena Bradatan iD, Kamal El Abd iD, Maria Beatrice Bilo iD, Federica Rivolta iD, Andrea Sangalli iD, Roxana Bumbacea iD, Selda Ali iD, Dario Antolin iD, Águeda Concepción Lario Cuenda und 5 weitere

Allergy · 2025-06 · 80 (6) · 1677-1701

DOI: 10.1111/all.16596 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Allergy, online erschienen am 20.05.2025. Verfasst von Ioana Agache und 16 weiteren Autor:innen. Beteiligte Einrichtung: Allergy & Clinical Immunology, Transylvania University, Brasov, Romania. Hauptthemen laut MEDLINE: Asthma, Hypersensitivity, Health Care Costs, Cost of Illness. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Health Economics of Allergic Diseases (HEAD) registry is a European‐based registry developed by the European Academy of Allergy and Clinical Immunology in collaboration with national allergy societies to facilitate standardised allergic disease management. Using an observational design, this first registry‐based study describes care patterns for allergic diseases and their impact on the healthcare system (diagnostic and management costs), society (missed work/school days and disability pension/support) and patients (out‐of‐pocket costs) in 778 adults and children with allergic rhinitis, asthma, atopic dermatitis and food allergy, from four countries (Belgium, Italy, Romania and Spain). The average total costs per patient and per year were €1329.55 ± 1947.39, with indirect costs of €338.68 ± 1629.61. Direct costs consisted of €82.74 ± 585.90 for hospitalisations, €17.50 ± 125.07 for the emergency department, €172.94 ± 323.17 for specialists, €22.70 ± 132.42 for primary care, €4.85 ± 136.84 for psychologists, €21.24 ± 82.47 for diagnosis and €104.81 ± 469.26 for treatments. Indirect costs were out‐of‐pocket consultation fees (€16.24 ± 106.40), medications (€161.90 ± 710.58), transportation (€44.15 ± 218.51), private insurance (€16.77 ± 157.91), avoidance (€8.65 ± 92.99) and environmental control (€99.33 ± 955.23). Adults missed 1.02 ± 3.20 workdays, children missed 0.53 ± 2.18 schooldays and burdened their families with 1.38 ± 13.83 lost days. There was a high degree of heterogeneity across countries for management patterns and for costs. The significant burden of allergic diseases calls for immediate action for better management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaHypersensitivityHealth Care CostsCost of IllnessHumansRegistriesAdultMaleFemaleChildEuropeMiddle AgedAdolescentChild, PreschoolYoung Adult

Stichwörter der Autor:innen

allergic diseasesasthmaeconomic impactregistry

Autor:innen und Institutionen

  • Allergy & Clinical Immunology, Transylvania University, Brasov, Romania.
  • Allergy Unit and Research Group, Hospital Regional Universitario de Malaga and IBIMA-Plataforma BIONAND, RICORS Inflammatory Diseases, Malaga, Spain.
  • Pneumology-Allergology Unit, Pediatrics Department, Centre Hospitalier Régional de Namur, Namur, Belgium.
  • Centre Pédiatrique d'Allergologie, CHC MontLégia, Liège, Belgium.
  • Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.
  • Allergy Unit, Department of Internal Medicine, University Hospital of Anconai Riposo e Cura per Anziani (INCRA), Ancona, Italy.

ORCID-Profile: Ioana Agache, Maria Torres, Ibon Eguiluz-Gracia, Elena Bradatan, Kamal El Abd, Maria Beatrice Bilo, Federica Rivolta, Andrea Sangalli, Roxana Bumbacea, Selda Ali, Dario Antolin, Vicente Albéndiz, Maria Miguel Oliveira, Paulo Jorge Nogueira, Loreto Carmona

Zitieren

APA

Agache, I., Torres, M., Eguiluz-Gracia, I., Bradatan, E., El Abd, K., Bilo, M. B., Rivolta, F., Sangalli, A., Bumbacea, R., Ali, S., Antolin, D., Cuenda, Á. C. L., Albéndiz, V., Oliveira, M. M., Nogueira, P. J., Carmona, L., & HEAD Study Group (2025). Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry. Allergy, 80(6), 1677-1701. https://doi.org/10.1111/all.16596

Vancouver

Agache I, Torres M, Eguiluz-Gracia I, Bradatan E, El Abd K, Bilo MB, et al. Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry. Allergy. 2025;80(6):1677-1701. doi:10.1111/all.16596

BibTeX
@article{Agache2025,
  author = {Agache, Ioana and Torres, Maria and Eguiluz-Gracia, Ibon and Bradatan, Elena and El Abd, Kamal and Bilo, Maria Beatrice and Rivolta, Federica and Sangalli, Andrea and Bumbacea, Roxana and Ali, Selda and Antolin, Dario and Cuenda, Águeda Concepción Lario and Albéndiz, Vicente and Oliveira, Maria Miguel and Nogueira, Paulo Jorge and Carmona, Loreto and HEAD Study Group, HEAD Study Group},
  title = {Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry},
  journal = {Allergy},
  year = {2025},
  volume = {80},
  number = {6},
  pages = {1677--1701},
  doi = {10.1111/all.16596}
}
Kostenlos starten →